What are the long-term goals of asthma management?
The long-term goals of asthma management are to achieve…
Which treatments should be considered when patients have inadequately controlled asthma on ICS/LABA?
More effective asthma treatments are needed as many patients still experience burdensome symptoms despite ICS/LABA treatment1–5
The role of LAMA, a bronchodilatory agent, as an add-on therapy to ICS/LABA in uncontrolled asthma4,6 needs to be evaluated further.
Which treatments should be considered when patients have inadequately controlled asthma on ICS/LABA?
More effective asthma treatments are needed as many patients still experience burdensome symptoms despite ICS/LABA treatment.1–5…
Speakers
Dr Xavier Soler/Dr Nicola Hanania
20
20
Related materials
Footnote
Produced in collaboration with CHEST; all copyrights and ownership are held by CHEST
References
- Bateman ED, et al. Am J Respir Crit Care Med. 2004;170:836–44.
- Davis J, et al. J Asthma. 2019;56:332–40.
- Hekking PW, et al. J Allergy Clin Immunol. 2015;135:896–902.
- GINA: Global Strategy for Asthma Management and Prevention 2022. Available from: www.ginasthma.org
- Ichinose M, et al. Allergol Int. 2017;66:163–89.
- Shaikh N, et al. Int J Chron Obstruct Pulmon Dis. 2017;12:1903–13.
Asthma Forward is a registered trade mark of the GSK group of companies.
©2022 GSK group of companies. All rights reserved.
SE-GBL-FVU-WCNT-200059 | February 2023